KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Other Non-Current Assets: 2017-2025

Historic Other Non-Current Assets for Aquestive Therapeutics (AQST) over the last 9 years, with Sep 2025 value amounting to $3.2 million.

  • Aquestive Therapeutics' Other Non-Current Assets fell 24.37% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 24.37%. This contributed to the annual value of $4.2 million for FY2024, which is 22.34% down from last year.
  • According to the latest figures from Q3 2025, Aquestive Therapeutics' Other Non-Current Assets is $3.2 million, which was down 0.28% from $3.2 million recorded in Q2 2025.
  • Aquestive Therapeutics' 5-year Other Non-Current Assets high stood at $7.8 million for Q1 2021, and its period low was $3.2 million during Q3 2025.
  • Moreover, its 3-year median value for Other Non-Current Assets was $4.2 million (2024), whereas its average is $4.7 million.
  • Per our database at Business Quant, Aquestive Therapeutics' Other Non-Current Assets skyrocketed by 2,620.49% in 2021 and then decreased by 24.37% in 2025.
  • Over the past 5 years, Aquestive Therapeutics' Other Non-Current Assets (MRQ) stood at $6.9 million in 2021, then decreased by 6.55% to $6.5 million in 2022, then decreased by 15.70% to $5.4 million in 2023, then dropped by 22.34% to $4.2 million in 2024, then dropped by 24.25% to $3.2 million in 2025.
  • Its Other Non-Current Assets stands at $3.2 million for Q3 2025, versus $3.2 million for Q2 2025 and $4.2 million for Q1 2025.